Remission Medical, Inc., a virtual rheumatology company that contracts directly with health systems to deliver embedded specialty care, announced the close of a Series A funding round led by Blue Heron Capital, an early-stage growth equity firm. The investment will fuel expansion of the company's partner network, grow its clinical workforce, and accelerate the scaling infrastructure that allows Remission Medical to rapidly deploy rheumatology access across more systems, more markets, and ultimately more specialties.